Nature Reviews Rheumatology, Published online: 25 February 2026; doi:10.1038/s41584-026-01364-8 Drawing on my contrasting experiences as a patient in oncology and […]
Nature Reviews Rheumatology, Published online: 25 February 2026; doi:10.1038/s41584-026-01352-y Inborn errors of metabolism are a diverse group of disorders that
Nature Reviews Rheumatology, Published online: 16 February 2026; doi:10.1038/s41584-026-01363-9 Author Correction: Inflammation and pain as interconnected targets in axial spondyloarthritis
Nature Reviews Rheumatology, Published online: 16 February 2026; doi:10.1038/s41584-026-01357-7 The emergence of potent depletion therapies for the treatment of refractory
Nature Reviews Rheumatology, Published online: 10 February 2026; doi:10.1038/s41584-026-01359-5 The findings of the pivotal RESET-RA trial demonstrate the clinical benefits
Nature Reviews Rheumatology, Published online: 10 February 2026; doi:10.1038/s41584-026-01360-y An erythrocyte-based strategy to achieve durable immunotolerance prevents the formation of
Nature Reviews Rheumatology, Published online: 03 February 2026; doi:10.1038/s41584-026-01353-x Non-invasive imaging of articular cartilage has evolved markedly and can be
Nature Reviews Rheumatology, Published online: 26 January 2026; doi:10.1038/s41584-025-01349-z Systemic sclerosis (SSc) is a severe fibrotic disease that affects multiple
Nature Reviews Rheumatology, Published online: 21 January 2026; doi:10.1038/s41584-025-01348-0 Although current treatments for axial spondyloarthritis can reduce inflammation, many patients
Nature Reviews Rheumatology, Published online: 07 January 2026; doi:10.1038/s41584-025-01350-6 A large European cohort clarifies COPA syndrome as a multi-organ interferonopathy
Nature Reviews Rheumatology, Published online: 05 January 2026; doi:10.1038/s41584-025-01347-1 Intravenous immunoglobulin (IVIG) is a cornerstone of autoimmune disease therapy, but
Nature Reviews Rheumatology, Published online: 19 December 2025; doi:10.1038/s41584-025-01344-4 Fibromyalgia remains a challenge for researchers and clinicians. Three studies published
Nature Reviews Rheumatology, Published online: 18 December 2025; doi:10.1038/s41584-025-01346-2 A new study reveals that the Epstein–Barr virus can reprogramme autoreactive
Nature Reviews Rheumatology, Published online: 15 December 2025; doi:10.1038/s41584-025-01342-6 New research published in 2025 sheds light on the pre-clinical period
Nature Reviews Rheumatology, Published online: 11 December 2025; doi:10.1038/s41584-025-01327-5 Monogenic disorders involving key elements of the TNF pathway now encompass
Nature Reviews Rheumatology, Published online: 10 December 2025; doi:10.1038/s41584-025-01343-5 In 2025, a new wave of ‘off-the-shelf’ B cell-depleting modalities for
Nature Reviews Rheumatology, Published online: 09 December 2025; doi:10.1038/s41584-025-01341-7 Autologous haematopoietic stem cell transplantation revolutionized the treatment of severe systemic
Nature Reviews Rheumatology, Published online: 08 December 2025; doi:10.1038/s41584-025-01333-7 In this Review, the authors summarize the potential role of emerging
Nature Reviews Rheumatology, Published online: 05 December 2025; doi:10.1038/s41584-025-01340-8 A new study uncovers how UBA1 mutations in VEXAS syndrome simultaneously
Nature Reviews Rheumatology, Published online: 03 December 2025; doi:10.1038/s41584-025-01337-3 Advances in artificial intelligence (AI) are transforming patient stratification in rheumatology.
Nature Reviews Rheumatology, Published online: 03 December 2025; doi:10.1038/s41584-025-01332-8 Emerging evidence suggests a paradigm shift in viewing osteoarthritis (OA) as
Nature Reviews Rheumatology, Published online: 02 December 2025; doi:10.1038/s41584-025-01296-9 Immune-checkpoint agonists are a promising therapeutic approach for autoimmune disease. This
Nature Reviews Rheumatology, Published online: 01 December 2025; doi:10.1038/s41584-025-01339-1 Many of the current therapies for arthritis lack a targeted approach,
Nature Reviews Rheumatology, Published online: 28 November 2025; doi:10.1038/s41584-025-01338-2 T helper 17 cells that lose IL-17 expression drive inflammation in
Nature Reviews Rheumatology, Published online: 27 November 2025; doi:10.1038/s41584-025-01329-3 In this Consensus Statement, a Group for Research and Assessment of
Nature Reviews Rheumatology, Published online: 26 November 2025; doi:10.1038/s41584-025-01335-5 A nanobody that targets IL-17A and IL-17F has shown promise in
Nature Reviews Rheumatology, Published online: 26 November 2025; doi:10.1038/s41584-025-01328-4 Cam morphology can cause intra-articular joint damage and lead to femoroacetabular
